Clinical and prognostic characteristics of metastatic colorectal cancer with minor RAS mutations
Yoshiki Kojitani, Daisuke Sakai, Takatsugu Ogata, Yumi Amano et autres
Metastatic colorectal cancer (mCRC) presents notable therapeutic challenges. Rat sarcoma virus (RAS) mutations, including those in KRAS exon 2, are critical for treatment decisions; however, the role of minor RAS mutations (KRAS exons 3 and 4, and NRAS) remains underexplored. Because these …
jp (code pays fourni par la source)